Note: Progenity's revenues are gauged from an analysis of company filings.
Progenity has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.
November 9, 2017
Complete list of funding rounds and total amounts in the Company Report
Progenity's Income Statement (based on Industry Averages)
$ Millions (Industry Average)
Progenity Revenue (Sales)
Cost of Goods Sold
Salaries and wages
Other Operating Expenses
Total Operating Expenses
EBIT (Earnings Before Interest and Taxes)
Trademark applications show the products and services that Progenity is developing and marketing.
Progenity's new tradmarks suggest it is investing in R&D and marketing, while expanding into new products or markets.
Trademarks may include brand names, product names, logos and slogans.
INNATAL medical laboratory services; genetic testing for scientific research and analysis purposes
RISCOVER medical laboratory services; genetic testing for scientific research and analysis purposes
PREPARENT Laboratory research and analysis services in the field of genetics; laboratory analysis for cystic fibrosis, spinal muscular atrophy, fragile X syndrome, autism, and other genetic conditions; laboratory analysis in the field of prenatal molecular genetic screening; scientific consultation services in the fields of laboratory testing and diagnostics
Patent applications show Progenity's intellectual property,
its current capabilities and future direction.
Progenity has applied for 2 patents since 2009.
Progenity's most recent patent was filed in October 2017 for Nucleic Acids And Methods For Detecting Methylation Status.The invention provides compositions and methods for determining whether a subject is predisposed to the disease or condition, or for diagnosing a disease or condition, or for detecting the state of a disease or condition, by detecting the methylation state of the subject's nucleic acids. In addition, the invention provides methods for determining the methylation age of a subject or tissue from a subject or for differentiation between nucleic acids originating from different subjects or tissues. The invention further provides methods for selecting nucleic acid molecules for use in the methods of the invention.
Complete list of patent applications
Determine whether Progenity grew or shrank during the last recession. This is useful in estimating the
financial strength and credit risk of the company.
Compare how recession-proof Progenity is relative to the industry overall.
While a new recession may strike a particular industry, measuring the
industry and company's robustness during the last recession estimates its ability to weather future recessions.
Market Share of Competition: Progenity vs. Largest Competitors
A competitive analysis shows these companies are in the same general field as Progenity, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Progenity.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as Progenity and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.